SCHEDULE 13G/A

Enanta Pharmaceuticals Inc

Common Stock, par value $0.01 per share · CUSIP: 29251M106

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 665,953.00 · Class: 2.3%

• Millennium Management LLC

  Shares: 670,428.00 · Class: 2.3%

• Millennium Group Management LLC

  Shares: 670,428.00 · Class: 2.3%

• Israel A. Englander

  Shares: 670,428.00 · Class: 2.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.